H.C. Wainwright Downgrades Karyopharm Therapeutics (KPTI) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 0.11 -0.55 (83.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.66 | 52 Week High | $19.41 | |||
| Open | $0.15 | 52 Week Low | $4.83 | |||
| Day High | $0.16 | P/E | N/A | |||
| Day Low | $0.09 | EPS | $-2.74 | |||
| Volume | 46,578,813 | |||||
